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Abstract
The bone marrow contains heterogeneous population of cells that are involved in the regeneration and repair of diseased
organs, including the lungs. In this study, we isolated and characterized progenitor epithelial cells from the bone marrow of
4- to 5-week old germ-free pigs. Microscopically, the cultured cells showed epithelial-like morphology. Phenotypically, these
cells expressed the stem cell markers octamer-binding transcription factor (Oct4) and stage-specific embryonic antigen-1
(SSEA-1), the alveolar stem cell marker Clara cell secretory protein (Ccsp), and the epithelial cell markers pan-cytokeratin
(Pan-K), cytokeratin-18 (K-18), and occludin. When cultured in epithelial cell growth medium, the progenitor epithelial cells
expressed type I and type II pneumocyte markers. Next, we examined the susceptibility of these cells to influenza virus.
Progenitor epithelial cells expressed sialic acid receptors utilized by avian and mammalian influenza viruses and were
targets for influenza virus replication. Additionally, differentiated type II but not type I pneumocytes supported the
replication of influenza virus. Our data indicate that we have identified a unique population of progenitor epithelial cells in
the bone marrow that might have airway reconstitution potential and may be a useful model for cell-based therapies for
infectious and non-infectious lung diseases.
Citation: Khatri M, Saif YM (2011) Epithelial Cells Derived from Swine Bone Marrow Express Stem Cell Markers and Support Influenza Virus Replication In
Vitro. PLoS ONE 6(12): e29567. doi:10.1371/journal.pone.0029567
Editor: Man-Seong Park, Hallym University, Republic of Korea
Received August 24, 2011; Accepted November 30, 2011; Published December 22, 2011
Copyright:  2011 Khatri, Saif. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: khatri.14@osu.edu
Introduction
Bone marrow contains a variety of stem cells that include
hematopoietic stem cells, mesenchymal stem cells or stromal cells
(MSC), and multipotent adult progenitor cells [1]. Many reports
using a variety of animal models have demonstrated that
bone marrow cells (BMCs) may have a role in the repair
and regeneration of injured lung, infarcted myocardium, and
damaged bone, tendon and cartilage [2,3,4,5,6,7,8]. BMCs
cultured in vitro can differentiate into type I, II, and basal and
airway epithelial cells and express the cystic fibrosis transmem-
brane conductance regulator (CFTR) protein [9]. BMCs have
been shown to improve survival and attenuate lung inflammation
in bleomycin- and endotoxin-induced lung injury [8,10,11,12].
Following infusion of BMCs in animal models, these cells
have been identified as type I and II alveolar epithelial cells,
endothelial cells, fibroblasts, and bronchial epithelial cells [12].
However, precise identity of specific subpopulation of BMCs that
engraft in the lung parenchyma and have regenerative potential is
still not clear.
Recently, Wong and colleagues [13] reported the isolation of
progenitor epithelial cells from mouse and human bone marrow.
These cells expressed Clara cell secretory protein (Ccsp), a marker
of airway progenitor cells [14], CD45 and mesenchymal markers
CD73, CD90, CD105. These cells differentiated into multiple
epithelial cell lineages, including type I and II pneumocytes in vitro.
Furthermore, these progenitor epithelial cells preferentially homed
to naphthalene-injured lung following intratracheal or systemic
inoculation.
Influenza viruses belong to the family Orthomyxoviridae and cause
highly contagious respiratory infections in humans and animals.
These viruses cause seasonal epidemics and infrequent pandemics
in humans. Seasonal influenza epidemics are responsible for
between 200,000 and 500,000 influenza-related deaths each year
[15]. Avian influenza viruses caused three human pandemics
during the last century. The 2009 pandemic, the first pandemic of
21
st century, was caused by a triple reassortant H1N1 influenza
virus of swine lineage [16]. In addition to seasonal and pandemic
viruses, highly pathogenic avian influenza (HPAI) H5N1 virus has
crossed species barrier to infect humans. As of August 9, 2011,
more than 500 human cases with over 300 deaths have been
reported worldwide [17]. H5N1 viruses replicate to higher titers in
lungs and extra-pulmonary tissues leading to acute respiratory
distress syndrome, multiple-organ dysfunction, lymphopenia, and
hemophagocytosis [18,19,20]. Influenza viruses, therefore, pose a
constant public health threat, and it is important to understand its
pathogenesis to devise effective control measures.
Swine are gaining popularity as a useful large animal model for
stem cell therapy for important human diseases or conditions such
as myocardial infarction, diabetes, atherosclerosis, traumatic brain
injury, retinal damage, and tooth regeneration [21,22,23,24,25].
Like humans, pigs are an outbred species. As well, they are similar
to humans in anatomy, physiology, and immune responses
[26,27,28,29]. Additionally, swine can serve as an excellent animal
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manifestations and pathogenesis of influenza in pigs closely
resemble to what is observed in humans. Furthermore, the
cytokine responses in branchoalveolar lavage (BAL) fluid from
swine influenza virus-infected pigs are also identical to that
observed in nasal lavage fluids of experimentally infected humans
[30]. These observations support that pigs serve as an excellent
animal model to study the pathogenesis of influenza virus [31].
In this study, we report the isolation of previously undocu-
mented progenitor epithelial cells in pig bone marrow that
expressed Clara cell secretory protein (Ccsp), a marker for lung
progenitor cells, and the stem cell markers octamer-binding
transcription factor (Oct4) and stage-specific embryonic antigen-1
(SSEA-1). These progenitor cells showed increased self-renewal
capacity and expressed epithelial cell markers such as pan-
cytokeratin (Pan-K), cytokeratin 18 (K-18), and occludin.
Importantly, these cells expressed receptors for both mammalian
and avian influenza viruses and were permissive to infection with
these viruses. The progenitor cells differentiated into type I and II
pneumocytes and type II pneumocytes also supported replication
of influenza virus. These data provide new insights into the
pathogenesis of influenza virus. Further, porcine progenitor
epithelial cells described here may serve as a useful model in
cellular therapy strategies for epithelial diseases.
Results
Characteristics of the progenitor epithelial cells
During the culture of BMCs for the isolation of mesenchymal
stromal cells (MSC), we observed colonies of epithelial cells
surrounded by mesenchymal cells. The colony cells exhibited
cuboidal morphology typical of epithelial cells (Fig. 1A).
To characterize epithelial colony cells, we expanded individual
colonies in vitro and performed immunocytochemistry by using a
panel of stem cell and epithelial cell-specific antibodies. We found
that the epithelial colony cells expressed Ccsp, Oct4, and SSEA-1
(Fig. 1B). We detected the expression of Oct4 in the nuclei,
whereas SSEA-1 was mainly found on the cell surface and in the
cytoplasm of the progenitor epithelial colony cells (Fig. 1B). The
colony cells expressed epithelial specific markers Pan-K, K-18, and
occludin (Fig. 1C) but not the mesenchymal markers CD29,
CD44, and CD90 (data not shown).
Figure 1. Characterization of progenitor epithelial cells isolated from pig bone marrow. (A) Colony morphology of progenitor epithelial
cells derived from bone marrow. (B) Expression of stem cells markers on progenitor epithelial cells. Epithelial colony cells from primary cell cultures
were examined for the expression of lung and other stem cell markers by using specific antibodies directed against Ccsp, Oct4 and SSEA-1. (C)
Expression of epithelial cell markers on progenitor epithelial cells. Primary cell cultures were examined for the expression of specific epithelial cell
markers: Pan-K, K-18, and occludin. (D–F) Absence of non-specific binding by progenitor epithelial cells. The cells were incubated with FITC-labeled
secondary antibodies (D) goat anti-rabbit (E) goat anti-mouse (F) donkey anti-goat antibodies. Nuclei were stained by DAPI.
doi:10.1371/journal.pone.0029567.g001
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To address the self-renewal and differentiation potential of these
progenitor epithelial cells, individual colonies were isolated from
primary cultures and seeded in tissue culture plates precoated with
collagen I in 50% epithelial growth medium and 50% MSC
conditioned medium (MSC-CM); referred to as epithelial
differentiation medium in the text. In epithelial differentiation
medium, the cells continued to grow, became flattened, and
appeared as thinly spread cell clusters (Fig. 2A). By day 5, the
expression of pro surfactant protein C (SPC) was detected in the
cytoplasm of these flattened cells (Fig. 2B). These features are
consistent with the type II pneumocytes. Also, expression of
aquaporin 5 (Aqua5) protein, a marker for type I pneumocytes was
detected on expanded cells which were significantly larger than
that of the parental primary epithelial colony cells (Fig. 2B). The
expression of SPC or Aqua5 was not detected on primary
undifferentiated cells. These results suggest that bone marrow
progenitor epithelial cells have the potential to differentiate into
type I and II like pneumocytes.
Detection of a-2,3- and a-2,6-linked sialic acid receptors
on progenitor epithelial cells
Influenza virus infects cells through binding to cell surface sialic
acid receptors. To examine the susceptibility of progenitor
epithelial cells to influenza virus, we first evaluated by flowcyto-
metry these cells for the presence of sialic acid receptors. The a-
2,3- and a-2,6-linked sialic acid receptors were detected on the
surface of progenitor epithelial cells by lectin staining. A majority
of progenitor cells (.95%) expressed both a-2,3- and a-2,6-linked
sialic acid receptors, indicating that viruses of both avian and
mammalian lineages might replicate in these cells (Fig. 3A).
Progenitor epithelial cells as targets for influenza virus
replication
After confirming the expression of sialic acid receptors on
progenitor epithelial cells, we next examined the susceptibility of
progenitor epithelial cells to mammalian and avian influenza
viruses. Cells were inoculated with SwIV, AvIV or HuIV at a
MOI of 1 for 1 hour (h). As shown in Fig. 3, infectious viruses were
observed
in culture supernatants after 24 h after infection and viral
titers slightly increased at 36 h. Among the viruses tested, SwIV
produced highest cellular lysis (Fig. 3B) and replicated to highest
titers followed by AvIV and HuIV (Fig. 3C). The production of
cytopathic effects required live, infectious virus because cell
cytotoxicity was not observed in heat-inactivated virus-infected
cultures (data not shown).
In addressing whether in vitro differentiated type I and II
pneumocytes are susceptible to influenza virus infection, progen-
itor cells were differentiated to type I and II pneumocytes for 5
days in epithelial differential medium. The differentiated cultures
were then exposed to SwIV. Co-immunostaining revealed SwIV
replication in differentiated type II pneumocytes as indicated by
the presence of viral proteins whereas no viral proteins were
detected in differentiated type I pneumocytes (Fig. 4).
Discussion
In this study, we report the isolation and identification of
previously undocumented stem/progenitor epithelial cells from
bone marrow of pigs. These cells expressed the stem/progenitor
cell markers Oct4, SSEA-1, and Ccsp, and the epithelial markers
Pan-K, K-18, and occludin. Upon culture in epithelial differen-
tiation media, these cells differentiated into type I and II
pneumocytes. Most importantly, progenitor cells were targets for
mammalian and avian influenza virus replication.
We detected the expression of Oct4 in progenitor epithelial
cells. Oct4, a member of the POU family of transcription factors,
is expressed in pluripotent stem cells such as embryonic stem cells,
induced pluripotent stem cells, and lung stem cells where it
regulates self-renewal and pluripotency [32,33]. These Oct4
+
colony cells also expressed other stem cell markers; SSEA-1, Ccsp
and epithelial markers; pan-K, K-18, and occludin. Clara cells,
airways progenitor cells in the lungs which have been involved in
lung regeneration and repair, also express Ccsp and cytokeratins
[14,32,34]. Importantly, these Oct4
+Ccsp
+ colony cells differen-
tiated into cells possessing Aqua5 and SPC which are markers for
type I and II like pneumocytes respectively. Expression of stem cell
markers in progenitor epithelial cells may, therefore, be associated
with differentiation potential of these cells.
The porcine progenitor epithelial cells reported in this study
share similarities with recently reported human and mouse cells
that both cell types express Ccsp, but unlike human and mouse
cells, porcine progenitor epithelial cells did not express mesenchy-
mal markers such as CD29, CD44 and CD90 [13]. Porcine
progenitor epithelial cells also expressed stem cell markers; Oct4
and SSEA-1; however, mouse and human cells were not tested for
expression of these markers [13]. Similar to human and mouse
bone marrow cells, porcine bone marrow progenitor cells
expressed both Ccsp and SPC. Ccsp and SPC expressing
broncho-alveolar stem cells (BACS) were recently identified in
adult mouse lung [35]. Mouse BACS were found to express
hematopoietic markers, whereas our porcine bone marrow
progenitor epithelial cells lacked the expression of these markers.
Figure 2. Differentiation potential of progenitor epithelial
cells. Epithelial colony cells were sub-cultured onto collagen I-coated
plates and cultured in epithelial cell differentiation medium; on day 5
the cells were examined for (A) morphology of control and
differentiated cells and (B) the expression of alveolar cell markers,
Aqua5 (a type I pneumocyte marker) and SPC (a type II pneumocyte
marker).
doi:10.1371/journal.pone.0029567.g002
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to passage 8 suggesting that these cells have extensive self-renewal
and proliferation properties.
The role of bone marrow stem cells in tissue regeneration
including lungs is well established [36,37,38,39]. However, the
precise identity of specific subpopulation of BMCs that has tissue
regeneration capacity is not known. As reported for human
progenitor epithelial cells, porcine Oct4
+ Ccsp
+ colony cells were
detected in the plastic-adherent fraction surrounded by mesen-
chymal cells [40]. Therefore, it is likely that the progenitor
epithelial cells were derived from mesenchymal precursors.
Previously, bone marrow and even cord blood MSC were shown
to have epithelial differentiation potential. Cord blood MSC when
cultured in vitro expressed lung-specific markers such as Ccsp, SPC,
and CFTR [41]. Intravenous administration of cord blood-MSC
into NOD-SCID mice resulted in a low level of airway
engraftment of the cord blood-MSC that expressed cytokeratin
and CFTR. Similarly, bone marrow MSC differentiated to type I
and II pneumocytes in vitro and following intravenous or
intratracheal administration, engrafted in recipient lung paren-
chyma as type I and II pneumocytes [3,42]. These observations
suggest that bone marrow MSC could serve as precursors of
differentiated epithelial cells. Moreover, in this study we observed
that progenitor epithelial cells when cultured in 50% MSC-CM
were able to differentiate into type I and II pneumocytes further
providing evidence that mesenchymal stroma is important for the
pluripotency of epithelial colony cells. Future work will be directed
to identify the molecular signals provided by the mesenchymal
precursors that regulate the differentiation potential of epithelial
progenitor cells.
Bone marrow cell therapy may be effective in conditions that
currently lack effective treatment. Stem cells isolated from different
anatomic niches of lungs [34,35,43,44,45] have been shown to
differentiate into multiple epithelial cell types following lung
injury. Our lab and Wong and colleagues [13] demonstrated the
existence of progenitor epithelial cells in the bone marrow of pigs
and humans respectively which are capable of differentiating into
type I and II pneumocytes suggesting that these cells will be
valuable for lung therapies. Functionally, type I pneumocytes are
important for gas exchange, water permeability and the regulation
Figure 3. Replication of influenza virus in progenitor epithelial cells. (A) Progenitor epithelial cells express a-2,3- and a-2,6-linked sialic acid
receptors. Progenitor epithelial cells were examined by flow cytometry for the expression of a-2,3- and a-2,6-linked sialic acid receptors. The cells
were stained with FITC-labelled Maackia amurensis lectin II (MAA) specific for a-2,3-linked sialic acid receptors and Sambucus niagra agglutinin (SNA),
specific for a-2,6-linked sialic acid receptors. MDCK cells were included as positive controls. Compared to unstained cells (black), cells stained with
lectins (red) showed right shift indicating positive staining. BM cells (progenitor bone marrow epithelial cells), MDCK (MDCK cells) (B) Progenitor
epithelial cells were infected with SwIV, AvIV or HuIV at a MOI of 1. All virus types tested induced cell cytotoxicity. (C) Virus replication kinetics in
primary culture of progenitor epithelial cells after virus infection at 1 MOI. Virus production in infected culture supernatants was measured by
titration in MDCK cells. The values are averages 6 S.D. of two separate experiments using progenitor epithelial cells from two different pigs in each
experiment (n=4).
doi:10.1371/journal.pone.0029567.g003
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lung surfactants that reduce the alveolar surface tension [46]. The
isolation and expansion of lung-derived autologous cells from
humans is difficult, whereas bone marrow progenitor cells can be
easily isolated and expanded. In other preliminary studies, we have
isolated progenitor epithelial cells from the lung of pigs. Future in
vivo experiments in pigs will be designed to compare the lung
repair potential of bone marrow- and lung-derived progenitor
epithelial cells following infection and/or LPS-induced lung injury.
Excessive virus replication, multi-organ failure, and hyperim-
mune activation have been detected in humans and laboratory
animals infected with HPAI H5N1 and with recreated 1918
pandemic influenza virus [47,48,49,50,51]. The mechanisms
responsible for deterioration of lung function and the loss of
capacity for lung repair after influenza virus infection are not well
understood. Although influenza virus primarily replicates in lung,
virus has been detected in extra pulmonary tissues including bone
marrow [52,53]. Our in vitro findings show that progenitor
epithelial cells in bone marrow are permissive to influenza virus
suggesting that in the event of influenza virus infection, bone
marrow progenitor cells may not be available to home to the
injured lung to participate in tissue repair. Additional experiments
are needed to confirm the infection of progenitor epithelial cells in
vivo and to delineate further their roles in local and lung repair
following infection with influenza virus.




expressing progenitor epithelial cells in the bone marrow of swine
which are capable of differentiating into type I and II
pneumocytes. Additionally, we have demonstrated that these cells
serve as targets for influenza virus infection. Further character-
ization of these progenitor cells may help in understanding the
pathogenesis of infectious and non-infectious epithelial diseases
and the mechanisms of lung injury repair.
Materials and Methods
Isolation and identification of bone marrow progenitor
epithelial cells
Femur bones were obtained from 4- to 6-week old germ-free
pigs. BMCs were isolated by previously described methods
[54,55,56]. Briefly, the tip of each bone was removed and the
marrow was harvested by inserting a syringe needle into one end
of the bone and flushing with Dulbecco’s Modified Eagle’s
Medium (DMEM; Gibco). The bone marrow cells were filtered
through a 70-mm nylon mesh filter (BD, Falcon, USA) and
mononuclear cells were obtained by density gradient centrifuga-
tion over Ficoll-Hypaque (gradient density 1.077). Cells (1–
5610
5/cm
2) were plated in 25 cm
2 cell culture flasks in DMEM
containing 10% fetal bovine serum, 2 mm L-glutamine, 1%
antibiotic solution (Gibco, USA). Cultures were incubated at 37uC
in a humidified atmosphere containing 95% air and 5% CO2. The
non-adherent cells were removed after 72 h of culture. Individual
epithelial colonies surrounded by mesenchymal cells were plucked
and were expanded in vitro by culturing in DMEM media.
Detection of stem cell and epithelial cell markers
Stem cell and epithelial cell markers on progenitor epithelial
cells were detected by immunofluorescence assay (IFA). Epithelial
colony cells were fixed in methanol: acetone (1:1) for 3 min at
room temperature and then blocked with 3% bovine serum
albumin (BSA) for 30 min. Cells were incubated at 4uC with
following primary antibodies: rabbit anti-human Oct4 (Santa Cruz
Biotechnology), mouse anti- human SSEA-1(Millipore), goat anti-
mouse cc10 (Santa Cruz Biotechnology), mouse anti-human pan
cytokeratin, mouse anti-human cytokeratin 18 (Sigma), rabbit
anti-human occludin (Invitrogen), mouse anti-human CD90, rat
anti-mouse CD44 and mouse anti-pig CD29 (BD Pharmingen).
After overnight incubation at 4uC, cells were washed and
incubated for 1 h at room temperature with the following
respective FITC-labeled secondary antibodies: donkey anti-goat
IgG, goat anti-rabbit IgG, and goat anti-mouse IgG (Sigma). Cell
nuclei were then counterstained with 49,6-diamidino-2-phenylin-
dole (DAPI).
Generation of bone marrow MSC-CM
Porcine bone marrow MSC were grown and expanded as
described above. When MSC reached at about 80% confluence,
medium was aspirated and cells were washed three times with
phosphate-buffered saline. Cells were cultured in serum-free
medium for 24 h. CM was removed and centrifuged to remove
cellular debris and used in epithelial differentiation assays.
Differentiation of bone marrow progenitor epithelial cells
into type I and type II pneumocytes
To analyze differentiation potential of porcine progenitor
epithelial cells, cells were seeded in culture dishes pre-coated with
collagen I. The cells were cultured in epithelial cell differentiation
medium containing 50% epithelial growth media supplemented
with bovine pituitary extract (70 mg/ml), human epidermal growth
factor (5 ng/ml), insulin (5 mg/ml), and hydrocortisone (0.5 mg/
ml) (MEGM, Lonza, Walkersville, MD) and 50% MSC-CM
medium. After 5 days of incubation at 37uC, cells were observed
for morphology and cells grown on coverslips were examined for
the expression of Aqua5 (marker for type I pneumocytes) and SPC
(marker for type II pneumocytes) by using goat anti-human Aqua5
(Santa Cruz Biotechnology) and rabbit anti-human SPC (Milli-
pore) primary antibodies by IFA as described above.
Detection of sialic acid receptors on progenitor epithelial
cells
Sialic acid receptors on progenitor epithelial cells were detected
by flowcytometry [57]. Madin-Darby canine kidney (MDCK) cells
have been shown to express both a-2,3-linked sialic acid receptors
and a-2,6-linked sialic acid receptors; avian and mammalian
Figure 4. Replication of influenza virus in differentiated
pneumocytes: Primary cells were subcultured onto collagen I-coated
plates in epithelial cell differentiation medium; on day 5 differentiated
cells were infected with SwIV and examined for the presence of viral
proteins at 24 h after infection. Type II pneumocytes, positive for SPC
marker (green) supported the replication of SwIV virus as indicated by
expression of viral NP protein (red). Cell nuclei were stained with DAPI
(blue). No viral proteins were detected in Aqua5 expressing (green) type
I pneumocytes.
doi:10.1371/journal.pone.0029567.g004
Influenza Virus Infection of Bone Marrow Cells
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were included as positive controls. The cells were incubated with
FITC-labeled Maackia amurensis lectin II (MAA) or Sambucus niagra
agglutinin (SNA) (EY Laboratories) at 4uC for 30 min in dark and
acquired by Accuri C6 flow cytometer (BD Accuri) and analyzed
using CFlow plus software (Accuri).
Viruses and infection of progenitor epithelial cells
Influenza virus strains; swine influenza virus (SwIV; Sw/OH/
07, H1N1), avian influenza virus (AvIV; Ch/NY/95, H7N2) and
human influenza virus (HuIV; Hu/OH/06, H1N1) were propa-
gated in 10-day-old embryonated chicken eggs (AvIV was kindly
provided by Dr. S.M. Goyal, Department of Veterinary
Population Medicine, University of Minnesota, Saint Paul, MN).
Progenitor epithelial cells were infected with SwIV, AvIV and
HuIV at a multiplicity of infection (MOI) of 1. After adsorption for
1 h, the cells were washed and fresh medium was added to the
cells. At intervals after infection, released viruses in culture
supernatants were titrated in MDCK cells [58].
To examine whether differentiated progenitor epithelial cells
support influenza virus infection, epithelial colony cells were
cultured in collagen I coated dishes for 5 days in epithelial cell
differentiation medium. On day 5, cells were infected with SwIV
and influenza viral nucleoprotein (NP) was detected at 24 h after
infection by IFA using mouse anti influenza A NP (Millipore) as
primary antibody and rhodamine-labelled goat anti-mouse
(Molecular Probes) as secondary antibody.
Acknowledgments
We are grateful to Dr. Linda Saif’s lab for providing the femur bones from
germ-free pigs. We also thank Dr. Michele Williams for critically reviewing
the manuscript.
Author Contributions
Conceived and designed the experiments: MK YMS. Performed the
experiments: MK. Analyzed the data: MK YMS. Wrote the paper: MK.
References
1. Dimmeler S, Zeiher AM, Schneider MD (2005) Unchain my heart: the scientific
foundations of cardiac repair. J Clin Invest 115: 572–583.
2. Awad HA, Boivin GP, Dressler MR, Smith FN, Young RG, et al. (2003) Repair
of patellar tendon injuries using a cell-collagen composite. J Orthop Res 21:
420–431.
3. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, et al. (2001)
Bone marrow-derived cells as progenitors of lung alveolar epithelium.
Development 128: 5181–5188.
4. Macpherson H, Keir P, Webb S, Samuel K, Boyle S, et al. (2005) Bone marrow-
derived SP cells can contribute to the respiratory tract of mice in vivo. J Cell Sci
118: 2441–2450.
5. Noel D, Djouad F, Jorgense C (2002) Regenerative medicine through
mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig
Drugs 3: 1000–1004.
6. Pelttari K, Steck E, Richter W (2008) The use of mesenchymal stem cells for
chondrogenesis. Injury 39(Suppl 1): S58–65.
7. Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as
cardiac therapeutics. Circ Res 95: 9–20.
8. Rojas M, Xu J, Woods CR, Mora AL, Spears W, et al. (2005) Bone marrow-
derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell
Mol Biol 33: 145–152.
9. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, et al. (2005) Adult
stem cells from bone marrow stroma differentiate into airway epithelial
cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 102:
186–191.
10. Gupta N, Su X, Popov B, Lee JW, Serikov V, et al. (2007) Intrapulmonary
delivery of bone marrow-derived mesenchymal stem cells improves survival and
attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:
1855–1863.
11. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, et al. (2007) Prevention
of LPS-induced acute lung injury in mice by mesenchymal stem cells
overexpressing angiopoietin 1. PLoS Med 4: e269.
12. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, et al. (2003)
Mesenchymal stem cell engraftment in lung is enhanced in response to
bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A
100: 8407–8411.
13. Wong AP, Keating A, Lu WY, Duchesneau P, Wang X, et al. (2009)
Identification of a bone marrow-derived epithelial-like population capable of
repopulating injured mouse airway epithelium. J Clin Invest 119: 336–348.
14. Giangreco A, Reynolds SD, Stripp BR (2002) Terminal bronchioles harbor a
unique airway stem cell population that localizes to the bronchoalveolar duct
junction. Am J Pathol 161: 173–182.
15. WHO (2009) Influenza (Seasonal) Fact sheet.
16. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic
and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses
Circulating in Humans. Science.
17. WHO (2011) Cumulative number of confirmed human cases of Avian Influenza
A/(H5N1) reported to WHO.
18. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, et al.
(1998) Human influenza A H5N1 virus related to a highly pathogenic avian
influenza virus. Lancet 351: 472–477.
19. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, et al. (1998)
Characterization of an avian influenza A (H5N1) virus isolated from a child
with a fatal respiratory illness. Science 279: 393–396.
20. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, et al. (1998) Clinical
features and rapid viral diagnosis of human disease associated with avian
influenza A H5N1 virus. Lancet 351: 467–471.
21. Chang C, Niu D, Zhou H, Zhang Y, Li F, et al. (2008) Mesenchymal stroma
cells improve hyperglycemia and insulin deficiency in the diabetic porcine
pancreatic microenvironment. Cytotherapy 10: 796–805.
22. Lim JH, Piedrahita JA, Jackson L, Ghashghaei T, Olby NJ (2010) Development
of a model of sacrocaudal spinal cord injury in cloned Yucatan minipigs for
cellular transplantation research. Cell Reprogram 12: 689–697.
23. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, et al. (2002)
Mesenchymal stem cell implantation in a swine myocardial infarct model:
engraftment and functional effects. Ann Thorac Surg 73: 1919–1925; discussion
1926.
24. Sonoyama W, Liu Y, Fang D, Yamaza T, Seo BM, et al. (2006) Mesenchymal
stem cell-mediated functional tooth regeneration in swine. PLoS One 1: e79.
25. Zhou L, Wang W, Liu Y, de Castro JF, Ezashi T, et al. (2011) Differentiation of
induced pluripotent stem cells of Swine into rod photoreceptors and their
integration into the retina. Stem Cells 29: 972–980.
26. Cozzi E, Tucker AW, Langford GA, Pino-Chavez G, Wright L, et al. (1997)
Characterization of pigs transgenic for human decay-accelerating factor.
Transplantation 64: 1383–1392.
27. Ibrahim Z, Busch J, Awwad M, Wagner R, Wells K, et al. (2006) Selected
physiologic compatibilities and incompatibilities between human and porcine
organ systems. Xenotransplantation 13: 488–499.
28. Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher JT, et al. (2008)
The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell
Mol Physiol 295: L240–263.
29. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, et al. (2008)
Disruption of the CFTR gene produces a model of cystic fibrosis in newborn
pigs. Science 321: 1837–1841.
30. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, et al. (1998) Local and
systemic cytokine responses during experimental human influenza A virus
infection. Relation to symptom formation and host defense. J Clin Invest 101:
643–649.
31. Kuiken T, Taubenberger JK (2008) Pathology of human influenza revisited.
Vaccine 26(Suppl 4): D59–66.
32. Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, et al. (2006) Identification of
pulmonary Oct-4+ stem/progenitor cells and demonstration of their suscepti-
bility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad
Sci U S A 103: 9530–9535.
33. Pan GJ, Chang ZY, Scholer HR, Pei D (2002) Stem cell pluripotency and
transcription factor Oct4. Cell Res 12: 321–329.
34. Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR (2001) Clara cell
secretory protein-expressing cells of the airway neuroepithelial body microen-
vironment include a label-retaining subset and are critical for epithelial renewal
after progenitor cell depletion. Am J Respir Cell Mol Biol 24: 671–681.
35. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al. (2005)
Identification of bronchioalveolar stem cells in normal lung and lung cancer.
Cell 121: 823–835.
36. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, et al. (1999)
Transplantability and therapeutic effects of bone marrow-derived mesenchymal
cells in children with osteogenesis imperfecta. Nat Med 5: 309–313.
37. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al. (2001)
Neovascularization of ischemic myocardium by human bone-marrow-derived
Influenza Virus Infection of Bone Marrow Cells
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e29567angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves
cardiac function. Nat Med 7: 430–436.
38. Okamoto R, Yajima T, Yamazaki M, Kanai T, Mukai M, et al. (2002) Damaged
epithelia regenerated by bone marrow-derived cells in the human gastrointes-
tinal tract. Nat Med 8: 1011–1017.
39. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, et al. (2002) Bone marrow-
derived stem cells target retinal astrocytes and can promote or inhibit retinal
angiogenesis. Nat Med 8: 1004–1010.
40. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, et al.
(2005) Clarification of the nomenclature for MSC: The International Society for
Cellular Therapy position statement. Cytotherapy 7: 393–395.
41. Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, et al. (2008)
Derivation of lung epithelium from human cord blood-derived mesenchymal
stem cells. Am J Respir Crit Care Med 177: 701–711.
42. van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, et al. (2009)
Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in
neonatal lung injury in rats. Am J Respir Crit Care Med 180: 1131–1142.
43. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR (2004) Basal cells are a
multipotent progenitor capable of renewing the bronchial epithelium.
Am J Pathol 164: 577–588.
44. Reynolds SD, Shen H, Reynolds PR, Betsuyaku T, Pilewski JM, et al. (2007)
Molecular and functional properties of lung SP cells. Am J Physiol Lung Cell
Mol Physiol 292: L972–983.
45. Summer R, Kotton DN, Sun X, Ma B, Fitzsimmons K, et al. (2003) Side
population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol
Physiol 285: L97–104.
46. Chen J, Chen Z, Narasaraju T, Jin N, Liu L (2004) Isolation of highly pure
alveolar epithelial type I and type II cells from rat lungs. Lab Invest 84: 727–735.
47. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of
proinflammatory cytokines in human macrophages by influenza A (H5N1)
viruses: a mechanism for the unusual severity of human disease? Lancet 360:
1831–1837.
48. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal
outcome of human influenza A (H5N1) is associated with high viral load and
hypercytokinemia. Nat Med 12: 1203–1207.
49. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate
immune response in lethal infection of macaques with the 1918 influenza virus.
Nature 445: 319–323.
50. Suzuki K, Okada H, Itoh T, Tada T, Mase M, et al. (2009) Association of
Increased Pathogenicity of Asian H5N1 Highly Pathogenic Avian Influenza
Viruses in Chickens with Highly Efficient Viral Replication Accompanied by
Early Destruction of Innate Immune Responses. J Virol.
51. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, et al. (2007) Role of host
cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.
J Virol 81: 2736–2744.
52. To KF, Chan PK, Chan KF, Lee WK, Lam WY, et al. (2001) Pathology of fatal
human infection associated with avian influenza A H5N1 virus. J Med Virol 63:
242–246.
53. Zhang Z, Zhang J, Huang K, Li KS, Yuen KY, et al. (2009) Systemic infection
of avian influenza A virus H5N1 subtype in humans. Hum Pathol 40: 735–739.
54. Comite P, Cobianchi L, Avanzini MA, Zonta S, Mantelli M, et al. (2010)
Isolation and ex vivo expansion of bone marrow-derived porcine mesenchymal
stromal cells: potential for application in an experimental model of solid organ
transplantation in large animals. Transplant Proc 42: 1341–1343.
55. Khatri M, O’Brien TD, Sharma JM (2009) Isolation and differentiation of
chicken mesenchymal stem cells from bone marrow. Stem Cells Dev 18:
1485–1492.
56. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999)
Multilineage potential of adult human mesenchymal stem cells. Science 284:
143–147.
57. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, et al.
(2007) Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type
i interferon response in polarized human bronchial epithelial cells. J Virol 81:
12439–12449.
58. Khatri M, Dwivedi V, Krakowka S, Manickam C, Ali A, et al. (2010) Swine
influenza H1N1 virus induces acute inflammatory immune responses in pig
lungs: a potential animal model for human H1N1 influenza virus. J Virol 84:
11210–11218.
Influenza Virus Infection of Bone Marrow Cells
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29567